AxoGen, Inc. (AXGN) vs Butterfly Network, Inc. (BFLY)
AxoGen, Inc. and Butterfly Network, Inc. are both Medical Devices companies. AxoGen, Inc. and Butterfly Network, Inc. are of similar size ($2.6B and $2.5B). Butterfly Network, Inc. grew revenue faster over the last twelve months: 28.1% against 23.6%. AxoGen, Inc. has the higher net margin (−13.4% vs −66.7%) and the higher return on invested capital (−4.99% vs −76.6%). Across the 18 metrics below, AxoGen, Inc. leads on 14 and Butterfly Network, Inc. on 4.
Valuation
Profitability
| Metric | AXGN | BFLY | Medical Devices median |
|---|---|---|---|
| Gross margin | 74.56% | 52.64% | 56.01% |
| Operating margin | (5.12%) | (70.79%) | (15.03%) |
| Net margin | (13.36%) | (66.74%) | (20.40%) |
| Free cash flow margin | 2.59% | (25.01%) | (7.24%) |
| Return on equity | (18.21%) | (35.46%) | (15.32%) |
| Return on assets | (13.15%) | (25.11%) | (19.72%) |
| Return on invested capital | (4.99%) | (76.64%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack